Cytokinetics should hear back from the FDA ... In the company's third-quarter results update, chief executive Robert Blum said that aficamten has a "next-in-class safety and efficacy profile ...

Cytokinetics' chief executive, Robert Blum, said the new deal with Royalty Pharma “reinforces our shared conviction in the value of our cardiac myosin-focused pipeline of drug candidates.” ...

Notable insider trades include Malik Fady Ibraham, EVP Research & Development at Cytokinetics, Inc. (CYTK), who sold 7300 shares on Dec 10 ’24, at $50.64 each, totaling $0.37 million. On Dec 02 ’24, ...

$10,000 of CYTOKINETICS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "General healthcare representation.

Savannah Chrisley has opened up about the support she’s received from her boyfriend, Robert Shiver, including how he wrote a letter to the judge during her mom Julie Chrisley‘s resentencing ...

Edgewise Therapeutics (NASDAQ: EWTX) is a small-cap pharmaceutical stock that has been all the rage recently. Shares are up 55% in the last three months and up 332% over the past 52 weeks.

After hours: January 17 at 6:11:16 PM EST ...

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all ...